Abcellera Biologics shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $140k | 31k | 4.54 |
| 2023-12-31 | $181k | 32k | 5.72 |
| 2023-09-30 | $158k | 34k | 4.60 |
| 2023-06-30 | $224k | 35k | 6.45 |
| 2023-03-31 | $275k | 36k | 7.55 |
| 2022-12-31 | $438k | 43k | 10.13 |
| 2022-09-30 | $447k | 45k | 9.90 |
| 2022-06-30 | $464k | 44k | 10.64 |
| 2022-03-31 | $458k | 47k | 9.75 |
| 2021-12-31 | $654k | 46k | 14.29 |
| 2021-09-30 | $850k | 42k | 20.04 |
| 2021-06-30 | $591k | 27k | 21.99 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors